Optical Coherence Tomography - Rescan During Dissection of Macular Membranes

Sponsor
Federal University of São Paulo (Other)
Overall Status
Unknown status
CT.gov ID
NCT02748421
Collaborator
Instituto Paulista de Estudos e Pesquisa em Oftalmologia (Other)
30
2
14

Study Details

Study Description

Brief Summary

In our study , the investigators will use the microscope with OCT ( Lumera with RESCAN OCT ) coupled to assess the extent , depth and change of retinal architecture in the perioperative period . Thus , they will evaluate what the optimal maneuvers of dissection of macular membranes to obtain a more satisfactory result of the rearrangement in the retinal layers . Furthermore , the use of OCT perioperative may dispense with the use of dyes , decreasing the concentration used or reduce the exposure time. Thus, they can get the potential decrease in retinal toxicity may be generated by them.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Lumera Microscope with OCT RESCAN
  • Procedure: Conventional Microscope
N/A

Detailed Description

The investigators will use the microscope with OCT (Lumera with RESCAN OCT) coupled to assess the extent, depth and change of retinal architecture in the perioperative period. Thus, they will evaluate what the optimal maneuvers of dissection of macular membranes to obtain a more satisfactory result of the rearrangement in the retinal layers. Furthermore, the use of OCT perioperative may dispense with the use of dyes, decreasing the concentration used or reduce the exposure time.

Materials and methods The investigators will evaluate 30 patients with changes in macular membranes with surgical removal of indication from the Retina and Vitreous outpatient sector of Unifesp - Paulista School of Medicine. The patients will be classified according to the diseases in the following groups: Macular Hole, Epiretinal Membrane, Traction Syndrome vitreomacular, and proliferative vitreoretinopathy of Retinal Detachment. Everyone will be informed about the risks and benefits of the study and sign an informed consent form. In the preoperative evaluation a complete ophthalmologic examination with complementary tests such as angiography and optical coherence tomography will be done.

Patients will undergo retinal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS. The team of surgeons will answer the questionnaire on the surgical difficulty regarding the identification and removal of macular membranes.

All patients will be assessed at 1, 7, 15, 30, 60 and 90 and 180 days after surgery, including the following tests:

  • Measurement of visual acuity with best correction

  • Previous Biomicroscopy

  • Indirect Funduscopy

  • tonometry

  • Optical coherence tomography (OCT)

  • Retinography Surgeries and procedures of the study groups will be conducted by the same team of surgeons and all surgeries and procedures will be carried out in IPEPO - Paulista Institute of Studies and Research in Ophthalmology / Vision Institute.

For each type of retinal disease, there will be a control group and a group OCT as detailed below: 1 - GROUP CONTROL The control group will undergo retinal surgery with conventional microscope without coupled OCT. This group will have its filmed and documented surgery. The team of surgeons will answer the questionnaire on the surgical difficulty regarding the identification and removal of macular membranes.

2 -GROUP OCT / RESCAN In the group microscope coupled to OCT, patients will undergo retinal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS and have their filmed and documented surgery. The team of surgeons will answer the questionnaire on the surgical difficulty regarding the identification and removal of macular membranes.

Statistical methodology All information will be presented by mean and standard deviation for the quantitative variables and absolute frequency (n) and relative (%) for qualitative variables.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Evaluation Use Optical Coherence Tomography - Rescan During Dissection of Macular Membranes : Pre and Post Operative Aspects
Study Start Date :
May 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2016
Anticipated Study Completion Date :
Jul 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Lumera Microscope with OCT RESCAN

in the group microscope coupled to OCT, patients will undergo retinal surgery using the Lumera microscope with Rescan OCT Zeiss

Procedure: Lumera Microscope with OCT RESCAN
macular membrane dissection with OCT RESCAN

Other: Conventional Microscope

control group without OCT RESCAN

Procedure: Conventional Microscope
macular membrane dissection without OCT RESCAN

Outcome Measures

Primary Outcome Measures

  1. Assess optimal maneuvers in macular membrane dissection [Day 0 (surgical day)]

    by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty)

Secondary Outcome Measures

  1. Compare the time of surgery between groups [Day 0 (surgical day)]

    by a questionnaire responded by surgeons (until 1 hour, between 1-2 hours, more than 2 hours

  2. describe the surgical difficulty for macular membrane dissection [Day 0]

    by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Visual acuity less than 20/60 in the affected eye

  • 18 years of both sexes

  • 1 diagnostics of the diseases Macular Hole,Epiretinal membrane,Traction Syndrome vitreomacular, vitreoretinopathy Proliferative Retina Detachment.

  • Indication of vitreoretinal surgery

Exclusion criteria:
  • Any previous eye surgery in the study eye

  • Better visual acuity than or equal to 20/60.

  • Any previous infection affecting any eye structure. transport costs and feeding of patients will be the responsibility of the researchers.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Federal University of São Paulo
  • Instituto Paulista de Estudos e Pesquisa em Oftalmologia

Investigators

  • Principal Investigator: Michel Farah, MD, PhD, Federal University of São Paulo UNIFESP

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michel Eid Farah, Michel Eid Farah, Federal University of São Paulo
ClinicalTrials.gov Identifier:
NCT02748421
Other Study ID Numbers:
  • 50991615.6.0000.5505
First Posted:
Apr 22, 2016
Last Update Posted:
Apr 22, 2016
Last Verified:
Apr 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Michel Eid Farah, Michel Eid Farah, Federal University of São Paulo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 22, 2016